Spirituality, Schizophrenia, and State Hospitals: Program Description and Characteristics of Self-Selected Attendees of a Spirituality Therapeutic Group
- 204 Downloads
Spiritual matters can be an important part in the recovery process of patients with schizophrenia. A spirituality-based therapeutic group was developed for patients hospitalized on a research specialty unit jointly operated by a state hospital and a research institute. This report offers a description of this program and examines potential associations between spirituality and coping in patients with schizophrenia who either attended or did not attend the inpatient spirituality group. We compared group attendees (n = 20) with non-attendees (n = 20) cross-sectionally, using measures of spirituality, self-efficacy (i.e. the confidence in one’s ability), quality of life, and hopefulness, and religious/personal demographic profiles. For the total sample, spirituality status was significantly correlated with self-efficacy for both social functioning and negative symptoms. Significant differences were found between group attendees and non-attendees for spirituality status, but not for self-efficacy or quality of life. For group attendees, spirituality status was significantly correlated with self-efficacy for positive symptoms, negative symptoms and social functioning. Group attendees were significantly more hopeful than non-attendees and hopefulness was significantly associated with degree of spirituality status. These findings lend support for offering spirituality groups and positive coping during recovery from psychiatric disabilities.
KeywordsSchizophrenia Spirituality State hospitals
Occupational Therapy students Therese Allen, Donna Roberto, Christina DePiano, Janice Leach, and Cate Hutchison assisted with the data collection.
Nadine Revheim has no commercial interests to disclose. William M. Greenberg is currently an employee of Forest Research Institute. Leslie Citrome, is a consultant for, has received honoraria from, or has conducted clinical research supported by the following: Abbott Laboratories, AstraZeneca Pharmaceuticals, Avanir Pharmaceuticals, Azur Pharma Inc, Barr Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, Forest Research Institute, GlaxoSmithKline, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Merck, Novartis, Pfizer Inc, and Vanda Pharmaceuticals.
- 4.Herth K: Development and refinement of an instrument to measure hope. Scholarly Inquiry for Nursing Practice: An International Journal 5(1):39–51, 1991Google Scholar
- 16.Rosenfeld MS: Spirituality, motivation and performance. Occupational Therapy Now 3:5–9, 2001Google Scholar
- 18.van Gestel-Timmermans H, van den Bogaard J, Brouwers E, Herth K, van Nieuwenhuizen C: Hope as a determinant of mental health recovery: a psychometric evaluation of the Herth Hope Index-Dutch version. Scandinavian Journal of Caring Sciences, PMID 20210899, 2010 (epub ahead of print)Google Scholar